We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

By HospiMedica International staff writers
Posted on 15 Jul 2015
Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer and more effective neurosurgery procedures.

The technology, called Optical Coherence Tomography (OCT), uses visible light echolocation imaging to create higher-resolution images than is possible with ultrasound. More...
OCT produces a color-coded map of a patient’s brain that shows which areas are and which are not cancer. Unlike X-ray, Computed Tomography (CT) scans or Positron Emission Tomography (PET) scans, OCT is safer for patients because it has no ionizing radiation.

A summary of the research was published in the June, 17, 2015 issue of the journal Science Translational Medicine. The researchers discovered that cancer cells in the brain lack the myelin sheaths found in healthy brain cells. The researchers used the characteristic OCT “signature” of brain tumors and developed a computer algorithm that could process that data automatically and generate a color-coded map with cancerous tissue in red, and healthy areas in green.

The researchers conducted the research using human brain tissue, and mice, and plan to begin human clinical trials in Summer 2015.

If successful, OCT would be a significant step forward in brain cancer imaging, and could provide live feedback from the area being operated on, showing where the cancer is located. In comparison, ultrasound has a much lower resolution, and Magnetic Resonance Imaging (MRI) scanners are more expensive, bulky, and take longer to operate.

The system could also potentially be adapted to detect cancers in other parts of the body, for example to help surgeons visualize and avoid damaging vulnerable blood vessels during surgery.

Alfredo Quinones-Hinojosa, MD, a professor of neurosurgery, neuroscience and oncology at the Johns Hopkins University School of Medicine (Baltimore, MD, USA), clinical leader of the research team, said, “As a neurosurgeon, I’m in agony when I’m taking out a tumor. If I take out too little, the cancer could come back; too much, and the patient can be permanently disabled. We think optical coherence tomography has strong potential for helping surgeons know exactly where to cut.”

Related Links:

John Hopkins School of Medicine



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Wound Irrigation Solution
Prontosan®
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.